Dusseldorf - Delayed Quote EUR
Verastem Inc. R (2VSA.DU)
6.15
-0.20
(-3.15%)
As of 9:30:13 AM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
101,538
149,718
95,050
108,662
Total Liabilities Net Minority Interest
130,431
92,344
47,659
21,103
Total Equity Gross Minority Interest
-28,893
57,374
47,391
87,559
Total Capitalization
11,831
97,460
71,917
87,808
Common Stock Equity
-28,893
57,374
47,391
87,559
Capital Lease Obligations
1,530
1,471
2,264
2,931
Net Tangible Assets
-28,893
57,374
47,391
87,559
Working Capital
63,988
117,302
71,207
87,150
Invested Capital
11,831
97,460
72,192
87,808
Tangible Book Value
-28,893
57,374
47,391
87,559
Total Debt
42,254
41,557
27,065
3,180
Share Issued
40,262
25,281.15
16,711.75
15,440.50
Ordinary Shares Number
40,262
25,281.15
16,711.75
15,440.50
12/31/2021 - 2/6/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3G0.BE Altimmune Inc
4.3070
-2.36%
PH4.DU CStone Pharmaceuticals
0.3280
+1.86%
IMR.SG AC Immune SA
1.3560
0.00%
473A.SG Adaptimmune Therapeutics PLC
0.2200
-2.65%
F6T.SG Fate Therapeutics Inc
1.1470
-4.18%
MDG1.F Medigene AG
0.1500
-31.51%
OCS Oculis Holding AG
17.89
+0.62%
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
SCPH scPharmaceuticals Inc.
2.6000
-0.38%
ZNTL Zentalis Pharmaceuticals, Inc.
1.5000
+2.04%